TrialAnnals of oncology : official journal of the European Society for Medical Oncology2026

Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial.

K L Jhaveri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.